MassMutual Private Wealth & Trust’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
N
MassMutual Private Wealth & Trust's FLNA Position: Q1 2025 in Review
MassMutual Private Wealth & Trust sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 29 shares — an estimated $68 sold.
MassMutual Private Wealth & Trust first reported a position in FLNA in Q1 2022 and held it in 5 quarters. The position peaked at $853 in Q3 2024. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.
- MassMutual Private Wealth & Trust reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
- MassMutual Private Wealth & Trust sold 29 Filana Therapeutics shares in Q1 2025, an estimated $68.
- MassMutual Private Wealth & Trust first reported a position in Filana Therapeutics in Q1 2022 and held it in 5 quarters.
- MassMutual Private Wealth & Trust's Filana Therapeutics position peaked at $853 in Q3 2024.
- 117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.
Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2025, filed 1 Apr 2025.